A
ASTEC
vs
B
BSE Sensex 30
Over the past 12 months, ASTEC has underperformed BSE Sensex 30, delivering a return of -13% compared to the BSE Sensex 30's +12% growth.
Stocks Performance
ASTEC vs BSE Sensex 30
Performance Gap
ASTEC vs BSE Sensex 30
Performance By Year
ASTEC vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Astec Lifesciences Ltd
Glance View
Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 506 full-time employees. The company went IPO on 2009-11-25. The firm operates through the Agrochemicals segment. The company manufactures a range of fungicides, insecticides, herbicides and intermediates for its global customers. The Company’s product and intermediates include triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans and heterocyclic sulfonyl chlorides. The company has two multipurpose production sites at Mahad.
